How Do Pfizer’s and Moderna’s COVID Vaccine Results Compare?
We’ve now heard interim results for two of the leading coronavirus vaccine candidates. Pfizer (NYSE: PFE) and BioNTech (NASDAQ: BNTX) announced initial data for their experimental COVID-19 vaccine BNT162b2 on Nov. 9, 2020. Moderna (NASDAQ: MRNA) followed up a week later with interim results for its coronavirus vaccine candidate, mRNA-1273. In this Motley Fool Live video recorded on Nov. 16, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com writer Keith Speights discuss how Pfizer’s and Moderna’s results compare.